← FDA ENFORCEMENT
D-0182-2025Class II

FDC Limited

Recalling firm
FDC Limited
Product type
Drug
Status
Ongoing
Report date
2025-01-15
Distribution
Nationwide
Product quantity
136,181 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Product description

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

Code / lot info

Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.